MedTrace Logo

Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium

NCT03166345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-07-12

No results posted yet for this study

Summary

Platelets rich plasma is simple source of growth factors and cytokines that can regulate endometrial growth for subgroup of thin endometrium women. It is an autologous source of this enhancing factors; therefore, there os no risk of using it within the same participant.

Conditions

  • Poor Endometrium

Interventions

OTHER

Treatment of Thin Endometrium

This is a trial to improve endometrial thickness by autologous injection of PRP into the Uterine Cavity compared with CSF or no treatment.

Sponsors & Collaborators

  • Ganna Hospital

    collaborator OTHER

  • Ibn Sina Hospital

    lead OTHER_GOV

Principal Investigators

  • Ayman S El-Gohary, MD · Ganna Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2018-03-30
Completion
2018-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03166345 on ClinicalTrials.gov